233 related articles for article (PubMed ID: 33055223)
21. The effect of methoxsalen on nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism in vivo.
Sellers EM; Ramamoorthy Y; Zeman MV; Djordjevic MV; Tyndale RF
Nicotine Tob Res; 2003 Dec; 5(6):891-9. PubMed ID: 14668073
[TBL] [Abstract][Full Text] [Related]
22. An association of CYP2A6 genotype and smoking topography.
Strasser AA; Malaiyandi V; Hoffmann E; Tyndale RF; Lerman C
Nicotine Tob Res; 2007 Apr; 9(4):511-8. PubMed ID: 17454707
[TBL] [Abstract][Full Text] [Related]
23. Porcine CYP2A polymorphisms and activity.
Skaanild MT; Friis C
Basic Clin Pharmacol Toxicol; 2005 Aug; 97(2):115-21. PubMed ID: 15998359
[TBL] [Abstract][Full Text] [Related]
24. A high-level expression of CYP2A in the lung of the suncus (Suncus murinus) and its role in the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
Mushiroda T; Ariyoshi N; Kimura K; Takahara E; Nagata O; Kato H; Kamataki T
Biochem Biophys Res Commun; 2000 Mar; 269(2):393-6. PubMed ID: 10708563
[TBL] [Abstract][Full Text] [Related]
25. Metabolites of a tobacco-specific lung carcinogen in nonsmoking women exposed to environmental tobacco smoke.
Anderson KE; Carmella SG; Ye M; Bliss RL; Le C; Murphy L; Hecht SS
J Natl Cancer Inst; 2001 Mar; 93(5):378-81. PubMed ID: 11238699
[TBL] [Abstract][Full Text] [Related]
26. A Cyp2a polymorphism predicts susceptibility to NNK-induced lung tumorigenesis in mice.
Hollander MC; Zhou X; Maier CR; Patterson AD; Ding X; Dennis PA
Carcinogenesis; 2011 Aug; 32(8):1279-84. PubMed ID: 21625009
[TBL] [Abstract][Full Text] [Related]
27. Key residues controlling phenacetin metabolism by human cytochrome P450 2A enzymes.
DeVore NM; Smith BD; Urban MJ; Scott EE
Drug Metab Dispos; 2008 Dec; 36(12):2582-90. PubMed ID: 18779312
[TBL] [Abstract][Full Text] [Related]
28. Inhibition and inactivation of cytochrome P450 2A6 and cytochrome P450 2A13 by menthofuran, β-nicotyrine and menthol.
Kramlinger VM; von Weymarn LB; Murphy SE
Chem Biol Interact; 2012 May; 197(2-3):87-92. PubMed ID: 22486895
[TBL] [Abstract][Full Text] [Related]
29. Toxicokinetic Interaction between Hepatic Disposition and Pulmonary Bioactivation of Inhaled Naphthalene Studied Using
Kovalchuk N; Zhang QY; Kelty J; Van Winkle L; Ding X
Drug Metab Dispos; 2019 Dec; 47(12):1469-1478. PubMed ID: 31594800
[TBL] [Abstract][Full Text] [Related]
30. CYP2A13 metabolizes the substrates of human CYP1A2, phenacetin, and theophylline.
Fukami T; Nakajima M; Sakai H; Katoh M; Yokoi T
Drug Metab Dispos; 2007 Mar; 35(3):335-9. PubMed ID: 17178771
[TBL] [Abstract][Full Text] [Related]
31. The CYP2A subfamily: function, expression and genetic polymorphism.
Raunio H; Rautio A; Pelkonen O
IARC Sci Publ; 1999; (148):197-207. PubMed ID: 10493259
[TBL] [Abstract][Full Text] [Related]
32. 'Smoking genes': a genetic association study.
Verde Z; Santiago C; Rodríguez González-Moro JM; de Lucas Ramos P; López Martín S; Bandrés F; Lucia A; Gómez-Gallego F
PLoS One; 2011; 6(10):e26668. PubMed ID: 22046326
[TBL] [Abstract][Full Text] [Related]
33. Effects of tobacco smoke on the gene expression of the Cyp1a, Cyp2b, Cyp2e, and Cyp3a subfamilies in mouse liver and lung: relation to single strand breaks of DNA.
Villard PH; Seree EM; Re JL; De Meo M; Barra Y; Attolini L; Dumenil G; Catalin J; Durand A; Lacarelle B
Toxicol Appl Pharmacol; 1998 Feb; 148(2):195-204. PubMed ID: 9473526
[TBL] [Abstract][Full Text] [Related]
34. Frequency of CYP2A6 gene deletion and its relation to risk of lung and esophageal cancer in the Chinese population.
Tan W; Chen GF; Xing DY; Song CY; Kadlubar FF; Lin DX
Int J Cancer; 2001 Mar; 95(2):96-101. PubMed ID: 11241319
[TBL] [Abstract][Full Text] [Related]
35. CYP2A13 expressed in human bladder metabolically activates 4-aminobiphenyl.
Nakajima M; Itoh M; Sakai H; Fukami T; Katoh M; Yamazaki H; Kadlubar FF; Imaoka S; Funae Y; Yokoi T
Int J Cancer; 2006 Dec; 119(11):2520-6. PubMed ID: 16988941
[TBL] [Abstract][Full Text] [Related]
36. Characterization of CYP2A13*2, a variant cytochrome P450 allele previously found to be associated with decreased incidences of lung adenocarcinoma in smokers.
D'Agostino J; Zhang X; Wu H; Ling G; Wang S; Zhang QY; Liu F; Ding X
Drug Metab Dispos; 2008 Nov; 36(11):2316-23. PubMed ID: 18669584
[TBL] [Abstract][Full Text] [Related]
37. Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism.
Oscarson M; McLellan RA; Gullstén H; Agúndez JA; Benítez J; Rautio A; Raunio H; Pelkonen O; Ingelman-Sundberg M
FEBS Lett; 1999 Oct; 460(2):321-7. PubMed ID: 10544257
[TBL] [Abstract][Full Text] [Related]
38. CYP2B6 is expressed in African Green monkey brain and is induced by chronic nicotine treatment.
Lee AM; Miksys S; Palmour R; Tyndale RF
Neuropharmacology; 2006 Mar; 50(4):441-50. PubMed ID: 16309716
[TBL] [Abstract][Full Text] [Related]
39. Early changes in gene expression induced by tobacco smoke: Evidence for the importance of estrogen within lung tissue.
Meireles SI; Esteves GH; Hirata R; Peri S; Devarajan K; Slifker M; Mosier SL; Peng J; Vadhanam MV; Hurst HE; Neves EJ; Reis LF; Gairola CG; Gupta RC; Clapper ML
Cancer Prev Res (Phila); 2010 Jun; 3(6):707-17. PubMed ID: 20515954
[TBL] [Abstract][Full Text] [Related]
40. Genetic polymorphism of CYP2A6 gene and tobacco-induced lung cancer risk in male smokers.
Ariyoshi N; Miyamoto M; Umetsu Y; Kunitoh H; Dosaka-Akita H; Sawamura Y; Yokota J; Nemoto N; Sato K; Kamataki T
Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):890-4. PubMed ID: 12223434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
